Orphan designation: Letermovir Treatment of cytomegalovirus disease in patients with impaired cell-mediated immunity, 06/06/2012 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 13:26

Orphan designation: Letermovir Treatment of cytomegalovirus disease in patients with impaired cell-mediated immunity, 06/06/2012 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-12-999

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters